Annual EBITDA:
-$266.36M-$31.00M(-13.17%)Summary
- As of today, VRDN annual EBITDA is -$266.36 million, with the most recent change of -$31.00 million (-13.17%) on December 31, 2024.
- During the last 3 years, VRDN annual EBITDA has fallen by -$187.07 million (-235.94%).
- VRDN annual EBITDA is now -543497.96% below its all-time high of -$49.00 thousand, reached on December 31, 2013.
Performance
VRDN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$106.45M-$12.90M(-13.79%)Summary
- As of today, VRDN quarterly EBITDA is -$106.45 million, with the most recent change of -$12.90 million (-13.79%) on June 30, 2025.
- Over the past year, VRDN quarterly EBITDA has dropped by -$34.81 million (-48.59%).
- VRDN quarterly EBITDA is now -256615.66% below its all-time high of $41.50 thousand, reached on December 31, 2013.
Performance
VRDN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$370.50M-$34.81M(-10.37%)Summary
- As of today, VRDN TTM EBITDA is -$370.50 million, with the most recent change of -$34.81 million (-10.37%) on June 30, 2025.
- Over the past year, VRDN TTM EBITDA has dropped by -$121.29 million (-48.67%).
- VRDN TTM EBITDA is now -570781.36% below its all-time high of -$64.90 thousand, reached on December 31, 2013.
Performance
VRDN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRDN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.2% | -48.6% | -48.7% |
| 3Y3 Years | -235.9% | -262.0% | -279.6% |
| 5Y5 Years | -553.6% | -1649.5% | -1175.5% |
VRDN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -235.9% | at low | -117.8% | at low | -256.2% | at low |
| 5Y | 5-Year | -553.6% | at low | -1983.3% | at low | -1175.5% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
VRDN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$106.45M(-13.8%) | -$370.50M(-10.4%) |
| Mar 2025 | - | -$93.55M(-7.1%) | -$335.69M(-12.8%) |
| Dec 2024 | -$266.36M(-13.2%) | -$87.35M(-5.0%) | -$297.70M(-5.8%) |
| Sep 2024 | - | -$83.15M(-16.1%) | -$281.48M(-12.9%) |
| Jun 2024 | - | -$71.64M(-29.0%) | -$249.22M(-5.4%) |
| Mar 2024 | - | -$55.55M(+21.9%) | -$236.41M(+6.6%) |
| Dec 2023 | -$235.37M(-82.3%) | -$71.13M(-39.8%) | -$253.13M(-9.6%) |
| Sep 2023 | - | -$50.89M(+13.5%) | -$230.87M(-28.3%) |
| Jun 2023 | - | -$58.84M(+18.6%) | -$179.98M(-19.6%) |
| Mar 2023 | - | -$72.27M(-47.9%) | -$150.54M(-44.7%) |
| Dec 2022 | -$129.13M(-62.9%) | -$48.87M(-66.2%) | -$104.03M(-6.6%) |
| Jun 2022 | - | -$29.41M(-14.2%) | -$97.61M(-13.4%) |
| Mar 2022 | - | -$25.75M(+9.5%) | -$86.08M(-9.4%) |
| Dec 2021 | -$79.29M(+27.9%) | -$28.45M(-103.1%) | -$78.71M(-11.0%) |
| Sep 2021 | - | -$14.00M(+21.6%) | -$70.94M(-14.3%) |
| Jun 2021 | - | -$17.87M(+2.8%) | -$62.04M(-23.5%) |
| Mar 2021 | - | -$18.38M(+11.1%) | -$50.26M(-26.5%) |
| Dec 2020 | -$109.97M(-169.9%) | -$20.68M(-304.7%) | -$39.73M(-36.8%) |
| Sep 2020 | - | -$5.11M(+16.0%) | -$29.05M(+17.2%) |
| Jun 2020 | - | -$6.08M(+22.5%) | -$35.10M(+7.4%) |
| Mar 2020 | - | -$7.86M(+21.4%) | -$37.88M(+9.1%) |
| Dec 2019 | -$40.75M | -$10.00M(+10.4%) | -$41.69M(+0.9%) |
| Sep 2019 | - | -$11.16M(-25.8%) | -$42.07M(-5.3%) |
| Jun 2019 | - | -$8.87M(+23.9%) | -$39.96M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.66M(-12.4%) | -$39.85M(-21.7%) |
| Dec 2018 | -$31.55M(-22.2%) | -$10.38M(-14.7%) | -$32.74M(-14.3%) |
| Sep 2018 | - | -$9.05M(-3.3%) | -$28.64M(-12.9%) |
| Jun 2018 | - | -$8.76M(-92.5%) | -$25.37M(-6.3%) |
| Mar 2018 | - | -$4.55M(+27.5%) | -$23.86M(+8.8%) |
| Dec 2017 | -$25.82M(-108.4%) | -$6.27M(-8.4%) | -$26.18M(-1.7%) |
| Sep 2017 | - | -$5.79M(+20.2%) | -$25.73M(-7.6%) |
| Jun 2017 | - | -$7.25M(-5.6%) | -$23.92M(-25.2%) |
| Mar 2017 | - | -$6.87M(-17.9%) | -$19.11M(-28.0%) |
| Dec 2016 | -$12.39M(-12.6%) | -$5.83M(-46.3%) | -$14.93M(-24.3%) |
| Sep 2016 | - | -$3.98M(-63.5%) | -$12.02M(-8.1%) |
| Jun 2016 | - | -$2.44M(+9.4%) | -$11.12M(+0.1%) |
| Mar 2016 | - | -$2.69M(+7.6%) | -$11.12M(-1.1%) |
| Dec 2015 | -$11.00M(-63.7%) | -$2.91M(+5.6%) | -$11.00M(-5.7%) |
| Sep 2015 | - | -$3.08M(-26.0%) | -$10.41M(-16.6%) |
| Jun 2015 | - | -$2.44M(+4.8%) | -$8.93M(-37.7%) |
| Mar 2015 | - | -$2.57M(-10.7%) | -$6.48M(-65.5%) |
| Dec 2014 | -$6.72M(>-9900.0%) | -$2.32M(-45.0%) | -$3.92M(-151.5%) |
| Sep 2014 | - | -$1.60M(-3952.8%) | -$1.56M(-2299.7%) |
| Dec 2013 | -$49.00K(+98.7%) | $41.50K(+139.0%) | -$64.90K(+79.6%) |
| Sep 2013 | - | -$106.40K(+49.9%) | -$318.60K(+58.0%) |
| Dec 2012 | -$3.88M | - | - |
| Dec 2012 | - | -$212.20K(+61.2%) | -$758.80K(-38.8%) |
| Sep 2012 | - | -$546.60K | -$546.60K |
FAQ
- What is Viridian Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Viridian Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Viridian Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of VRDN is -$266.36M
What is the all-time high annual EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual EBITDA is -$49.00K
What is Viridian Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, VRDN annual EBITDA has changed by -$31.00M (-13.17%)
What is Viridian Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of VRDN is -$106.45M
What is the all-time high quarterly EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly EBITDA is $41.50K
What is Viridian Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, VRDN quarterly EBITDA has changed by -$34.81M (-48.59%)
What is Viridian Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of VRDN is -$370.50M
What is the all-time high TTM EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM EBITDA is -$64.90K
What is Viridian Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, VRDN TTM EBITDA has changed by -$121.29M (-48.67%)